Identification of BAG2 and Cathepsin D as Plasma Biomarkers for Parkinson’s Disease

The current diagnosis of Parkinson’s disease (PD) mostly relies on clinical rating scales related to motor dysfunction. Given that clinical symptoms of PD appear after significant neuronal cell death in the brain, it is required to identify accessible, objective, and quantifiable biomarkers for earl...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Juhee, Kim, Jae Whan, Heo, Hansol, Lee, Jihyun, Park, Kwan Yong, Yoon, Jung Han, Chang, Jaerak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993325/
https://www.ncbi.nlm.nih.gov/pubmed/33202088
http://dx.doi.org/10.1111/cts.12920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993325/
https://www.ncbi.nlm.nih.gov/pubmed/33202088
http://dx.doi.org/10.1111/cts.12920

Ejemplares similares